METHOTREXATE IN PSORIASIS - REVISED GUIDELINES

被引：293
作者：
ROENIGK, HH
AUERBACH, R
MAIBACH, HI
WEINSTEIN, GD
机构：
[1] UNIV CALIF SAN FRANCISCO, MED CTR, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF IRVINE, COLL MED, DEPT DERMATOL, IRVINE, CA 92717 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1988年 / 19卷 / 01期
关键词：
D O I：
10.1016/S0190-9622(88)80237-8
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：145 / 156
页数：12
相关论文
共 100 条
[1]  
AHERNE GW, 1981, CANCER TREAT REP, V65, P55
[2]   PROLONGATION AND ENHANCEMENT OF SERUM METHOTREXATE CONCENTRATIONS BY PROBENECID [J].
AHERNE, GW ;
PIALL, E ;
MARKS, V ;
MOULD, G ;
WHITE, WF .
BRITISH MEDICAL JOURNAL, 1978, 1 (6120) :1097-1099
[3]   LEUKOCYTE MIGRATION-INHIBITION IN METHOTREXATE-INDUCED PNEUMONITIS - EVIDENCE FOR AN IMMUNOLOGICAL CELL-MEDIATED MECHANISM [J].
AKOUN, GM ;
GAUTHIERRAHMAN, S ;
MAYAUD, CM ;
TOUBOUL, JL ;
DENIS, MF .
CHEST, 1987, 91 (01) :96-99
[4]   CRYPTOCOCCOSIS ASSOCIATED WITH LOW-DOSE METHOTREXATE FOR ARTHRITIS [J].
ALTZSMITH, M ;
KENDALL, LG ;
STAMM, AM .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (01) :179-181
[5]   COMPLICATIONS IN METHOTREXATE TREATMENT OF PSORIASIS WITH PARTICULAR REFERENCE TO LIVER FIBROSIS [J].
ASHTON, RE ;
MILLWARDSADLER, GH ;
WHITE, JE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 (04) :229-232
[6]  
BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO
[7]  
2-E
[8]   IS METHOTREXATE THERAPY FOR PSORIASIS CARCINOGENIC - MODIFIED RETROSPECTIVE PROSPECTIVE ANALYSIS [J].
BAILIN, PL ;
TINDALL, JP ;
ROENIGK, HH ;
HOGAN, MD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 232 (04) :359-362
[9]   TOXIC HEPATITIS DUE TO COMBINATION THERAPY WITH METHOTREXATE AND ETRETINATE IN PSORIASIS [J].
BECK, HI ;
FOGED, EK .
DERMATOLOGICA, 1983, 167 (02) :94-96
[10]   CLINICAL-PHARMACOLOGY OF METHOTREXATE [J].
BERTINO, JR .
MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (04) :401-411
12345678910